Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure

作者: Hans L. Hillege , Dorothea Nitsch , Marc A. Pfeffer , Karl Swedberg , John J.V. McMurray

DOI: 10.1161/CIRCULATIONAHA.105.580506

关键词:

摘要: Background— Decreased renal function has been found to be an independent risk factor for cardiovascular outcomes in patients with chronic heart failure (CHF) markedly reduced left ventricular ejection fraction (LVEF). The aim of this analysis was evaluate the prognostic importance a broader spectrum CHF. Methods and Results— Candesartan Heart Failure:Assessment Reduction Mortality Morbidity (CHARM) program consisted three component trials that enrolled symptomatic CHF, based on use ACE inhibitors (≤40%) or preserved LVEF (>40%). Entry baseline creatinine required below 3.0 mg/dL (265 μmol/L). Routine serum assessments were done 2680 North American patients. An estimated glomerular filtration rate (eGFR), using Modification Diet Renal Disease equation death hospitalization failure, as well all-cause mo...

参考文章(37)
Susanne Ljungman, John H. Laragh, Robert J. Cody, Role of the Kidney in Congestive Heart Failure Relationship of Cardiac Index to Kidney Function Drugs. ,vol. 39, pp. 10- 21 ,(1990) , 10.2165/00003495-199000394-00004
Guruprasad Manjunath, Mark J. Sarnak, Andrew S. Levey, Prediction equations to estimate glomerular filtration rate: an update Current Opinion in Nephrology and Hypertension. ,vol. 10, pp. 785- 792 ,(2001) , 10.1097/00041552-200111000-00009
Daniel L Dries, Derek V Exner, Michael J Domanski, Barry Greenberg, Lynne W Stevenson, The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. Journal of the American College of Cardiology. ,vol. 35, pp. 681- 689 ,(2000) , 10.1016/S0735-1097(99)00608-7
Ramachandran S Vasan, Alexa Beiser, Ralph B D'Agostino, Daniel Levy, Jacob Selhub, Paul F Jacques, Irwin H Rosenberg, Peter WF Wilson, Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction. JAMA. ,vol. 289, pp. 1251- 1257 ,(2003) , 10.1001/JAMA.289.10.1251
Bruce F. Culleton, Martin G. Larson, Peter W.F. Wilson, Jane C. Evans, Patrick S. Parfrey, Daniel Levy, Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney International. ,vol. 56, pp. 2214- 2219 ,(1999) , 10.1046/J.1523-1755.1999.00773.X
Amit X. Garg, William F. Clark, R. Brian Haynes, Andrew A. House, Moderate renal insufficiency and the risk of cardiovascular mortality: Results from the NHANES I Kidney International. ,vol. 61, pp. 1486- 1494 ,(2002) , 10.1046/J.1523-1755.2002.00270.X
Susanne Ljungman, John Kjekshus, Karl Swedberg, Consensus Trial Group, Renal function in severe congestive heart failure during treatment with enalapril (the Cooperative North Scandinavian Enalapril Survival Study [CONSENSUS] Trial). American Journal of Cardiology. ,vol. 70, pp. 479- 487 ,(1992) , 10.1016/0002-9149(92)91194-9
Hans L. Hillege, Armand R. J. Girbes, Pieter J. de Kam, Frans Boomsma, Dick de Zeeuw, Andrew Charlesworth, John R. Hampton, Dirk J. van Veldhuisen, Renal function, neurohormonal activation, and survival in patients with chronic heart failure Circulation. ,vol. 102, pp. 203- 210 ,(2000) , 10.1161/01.CIR.102.2.203
Atsushi Kambara, Bethany J Holycross, Peter Wung, Brandon Schanbacher, Sarbani Ghosh, Sylvia A McCune, John A Bauer, Pawel Kwiatkowski, None, Combined effects of low-dose oral spironolactone and captopril therapy in a rat model of spontaneous hypertension and heart failure. Journal of Cardiovascular Pharmacology. ,vol. 41, pp. 830- 837 ,(2003) , 10.1097/00005344-200306000-00002